Octagon Capital Advisors »

Kymera Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $20M 360k 56.60
2025-06-30 $12M 266k 43.64
2021-06-30 $4.9M 100k 48.50